Key Points
CORBEVAX, which was Indias first indigenously developed Covid-19 vaccine based on the protein sub-unit platform, was approved in India for restricted use in emergency for adults, adolescents as well as young children as well as a heterologous booster dose for those aged 18 years and above in India...
The Hyderabad-based vaccine maker has already supplied 100 million doses of CORBEVAX to the Indian government for pan-India immunisation campaigns..
Biological E Ltd managing director Mahima Datla said the WHO EUL would help the company use the platform to continue developing Covid-19 vaccines as and when it starts impacting public health...
She pointed out that while several companies entered vaccine development and manufacturing during the Covid-19 pandemic and exited soon afterwards either due to paucity of funds or lack of success, BE was committed to developing and providing access to high quality affordable vaccines globally by constantly enlarging its portfolio of offerings..
You might be interested in
Covishield side effects: Doctors' group calls for reviewing all Covid vaccines
13, May, 24The doctors associated with the Awaken India Movement (AIM) expressed the urgent need for a thorough review of the scientific data behind all Covid-19 vaccines following AstraZeneca's admittance of rare side effects in its Covid vaccine in court documents.
India’s first mRNA-based Omicron-specific booster vaccine from Pune-based Gennova gets DCGI approval
20, Jun, 23Gennova Biopharmaceuticals' mRNA Covid-19 booster vaccine, 'Gemcovac Om', has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'.
India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report
20, Apr, 23Only China, India, and Mexico, that is three out of the 55 countries studied for popular perception of the importance of vaccines for children, showed improvement as per data collected by The Vaccine Confidence Project (London School of Hygiene and Tropical Medicine) and published by UNICEF on April 20.
Covid vaccine mission is a lesson for the world
27, Feb, 23Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and nasal drop vaccine within two years
With COVID-19 ‘over’, applying the lessons learnt
08, May, 23In addition, The government needs to integrate the COVID-19 response to general health services
Booster doses of index virus-based vaccines still effective against all COVID-19 variants: WHO
16, Apr, 23The World Health Organisation said booster doses of index virus-based vaccines continue to confer high levels of protection against severe disease and death caused by all SARS-CoV-2 variants, including contemporary Omicron descendent lineages.
Gennova Biopharma seeks DCGI nod for its Omicron booster
20, Mar, 23Gennova has developed an Omicron specific vaccine GEMCOVAC-OM which has been assessed for its safety and immunogenicity when administered as a booster in participants who have received two doses of Covishield and Covaxin, the two main Covid-19 vaccines used in the immunisation drive.